Ironwood Pharmaceuticals, Inc.
-
Ticker
IRWD
-
Industry
Drugs - Generic More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Cambridge, Massachusetts
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in
…More the United States and Constella name in the European Union.
REPORT RATINGS
5.0 / 5.0 (1)
Ironwood Pharmaceuticals, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Ironwood Pharmaceuticals, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social and Governance Report
Report Locked. Ironwood Pharmaceuticals, Inc. has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Ironwood Pharmaceuticals, Inc. Sustainability Report, Ironwood Pharmaceuticals, Inc. Corporate Social Responsibility Report, Ironwood Pharmaceuticals, Inc. CSR Report, Ironwood Pharmaceuticals, Inc. Corporate Responsibility, Ironwood Pharmaceuticals, Inc. CR Report, Ironwood Pharmaceuticals, Inc. Citizenship Report, Ironwood Pharmaceuticals, Inc. ESG Report, and Ironwood Pharmaceuticals, Inc. Environmental Report online.